Drug­mak­ers ex­ploit can­cer’s ‘lethal­i­ties’ to make next class of tar­get­ed ther­a­pies, with first re­sults for Wern­er drug

CHICA­GO — A new type of tar­get­ed can­cer drug that blocks a “DNA care­tak­er” pro­tein called Wern­er he­li­case has cap­tured the at­ten­tion of sev­er­al big phar­ma …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER